date:Dec 29, 2012
erstanding and availability of complete genome sequences is rapidly becoming a key requirement for safety of probiotics across the globe. The sequencing of the BLIS K12 genome is significant because it allows the company and other independent researchers to rapidly identify the presence (or absence) of nucleotide sequences that are associated with undesirable traits such as virulence factors or antibiotic resistance genes.
The BLIS K12 genome does not contain phenotypically active gene sequenc